Vivani Medical, Inc.
NASDAQ:VANI · NASDAQ Capital Market
+$0.02 today
Vol 0.09M · Avg 0.24M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-169.2%
avg -346.3%
ROIC
-79.7%
avg -270.8%
ROA
-67.5%
avg -146.8%
Analysis
ROA is currently the strongest return metric at -67.5% versus its period average of -146.8%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Adam Mendelsohn | Co-Founder, Chief Executive Officer & Director | $624,000.00 | — | 44 | $188,170.00 | 0.32% |
Truc Le | Chief Operations Officer | $494,000.00 | — | 73 | $160,000.00 | 0.27% |
Lisa E. Porter | Chief Medical Officer | $493,800.00 | — | 62 | $40,000.00 | 0.07% |
Anthony Edward Baldor | Chief Financial Officer | $421,388.00 | — | 44 | $0.00 | <0.01% |
Donald Dwyer | Chief Business Officer & Corporate Secretary | $190,969.00 | — | 67 | $70,000.00 | 0.12% |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
20
$28.02M
Sells
0
$0.00
Net Sentiment
+$28.02M
Net buying
Most Active
Williams Gregg
19 transactions
1–10 of 20
Analysis
Insiders reported 20 buys worth $28.02M and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $28.02M. Williams Gregg was the most active insider with 19 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | +36.6% | +20.0% (14yr)1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Recent growth has been strongest in Revenue at +36.6% over three years. Forward estimates point to Revenue at +20.0% (14yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Edap Tms S.a.
EDAP
$178.23M
Quipt Home Medical Corp.
QIPT
$162.30M
Oramed Pharmaceuticals Inc.
NASDAQ:ORMP
$156.75M
Hyperfine, Inc.
NASDAQ:HYPR
$134.34M
Cardiol Therapeutics Inc.
NASDAQ:CRDL
$122.76M
FONAR Corporation
NASDAQ:FONR
$117.76M
AVITA Medical, Inc.
NASDAQ:RCEL
$98.50M
Microbot Medical Inc.
NASDAQ:MBOT
$82.97M
ImageneBio Inc
NASDAQ:IMA
$68.07M
InspireMD, Inc.
NSPR
$33.26M
Who manages VANI?
Vivani Medical, Inc. (VANI) lists 5 active executives. The top listed executive is Adam Mendelsohn, Co-Founder, Chief Executive Officer & Director.
Are VANI insiders buying or selling?
Recent insider activity shows net buying of $39.86M.
Explore More
Continue the stock analysis
Jump to another research area for this company.